Épisodes

  • 2303: The Exchange with Richard Crow (alias Cockney Rebel).

    2303: The Exchange with Richard Crow (alias Cockney Rebel).
    Feb 2 2026

    In this investing masterclass, expert stock picker Richard Crow (alias Cockney Rebel) takes me through his view of the markets and latest thoughts on 20 stock ideas:

    00:00 Recent portfolio returns, equity outlook and cash position
    06:00 Goodwin
    19:15 Saga
    30:45 Funding Circle
    37:25 Zotefoams
    43:40 Marshalls
    47:55 SRT Marine
    51:25 Filtronic
    54:50 Carclo
    57:25 Mpac
    60:00 Dialight
    1:05:20 AudioBoom
    1:07:30 Marston’s
    1:12:20 theWorks
    1:16:05 Card Factory
    1:19:55 CML Microsystems
    1:22:15 Warpaint
    1:24:10 Other top stock ideas for next 12 months: Journeo, Victrex and S4 Capital

    #GDWN #SAGA #FCH #ZTF #MSLH #SRT #FTC #CAR #MPAC #DIA #BOOM #MARS #WRKS #CARD #CML #W7L #JNEO #JNEO #VCT #SFOR
    Voir plus Voir moins
    1 h et 30 min
  • 2302: The most extraordinary week in commodities I've ever witnessed

    2302: The most extraordinary week in commodities I've ever witnessed
    Feb 2 2026

    Watch on Youtube

    SP Angel's John Meyer joins Vox to discuss the incredible events in the gold and commodities markets over the past week or so, and to pick out some of his favourite stocks amongst the junior and mid-tier miners. Stocks covered include:

    Anglo Asian
    Hochschild Mining
    Fresnillo
    Greatland Gold
    Aterian
    Cornish Metals
    Kodal Minerals
    Atlantic Lithium
    Harena Rare Earths

    Voir plus Voir moins
    24 min
  • 2301: Tharisa set for huge growth amidst backdrop of rising PGM prices

    2301: Tharisa set for huge growth amidst backdrop of rising PGM prices
    Jan 30 2026
    Tharisa has a well-established track record of chrome and platinum group metals production, and is now on the cusp of delivering significant growth through a move underground at its flagship South African mine and the establishment of new lines of production from a major new Zimbabwean project. The company is keeping a tight rein on costs, even as rising commodities prices push margins up, and it's in that context that the shares have doubled over the past 12 months. Even so, CEO Phoevos Pouroulis still argues that the company is undervalued compared to its peers. He joins us to tell us why he thinks that, and to provide details of what will happen next
    Voir plus Voir moins
    20 min
  • 2300: Quantum Data Energy: Q1 Update and Strategy Outlook

    2300: Quantum Data Energy: Q1 Update and Strategy Outlook
    Jan 30 2026
    In this interview, Quantum Data Energy #MAST CEO Pieter Krügel joins Vox Markets to discuss the Company’s Q1 investor update, recent re-branding, and the strategic evolution of the business. Pieter outlines how Quantum Data Energy is building on its flexible generation foundations, why data led infrastructure is becoming increasingly relevant, and how the Company is approaching growth with a clear focus on execution and capital discipline.
    Voir plus Voir moins
    6 min
  • 2299: Poolbeg Pharma: POLB 001 Clinical Data Published — What’s Next for This Immunomodulatory Asset?

    2299: Poolbeg Pharma: POLB 001 Clinical Data Published — What’s Next for This Immunomodulatory Asset?
    Jan 29 2026
    Following the publication of a peer-reviewed paper in Frontiers in Immunology detailing results from the POLB 001 LPS challenge trial, we catch up with Poolbeg Pharma’s CEO Jeremy Skillington and COO Liam Tremble.
    Voir plus Voir moins
    9 min
  • 2298: hVIVO: Staying Resilient and Ready – CEO Mo Khan on 2025 Performance and the Road Ahead

    2298: hVIVO: Staying Resilient and Ready – CEO Mo Khan on 2025 Performance and the Road Ahead
    Jan 29 2026
    In this exclusive conversation, hVIVO CEO Yamin ‘Mo’ Khan joins us to discuss the company’s FY2025 trading update, which delivered revenue in line with expectations and adjusted EBITDA ahead of guidance. Mo reflects on the successful integration of CRS and Cryostore, the company’s strategic repositioning beyond human challenge trials, and how hVIVO is navigating a shifting clinical research landscape. With momentum building across all service lines, Mo also shares what investors can look forward to in 2026.
    Voir plus Voir moins
    11 min
  • 2297: 2 P’s on a Pod: Small Cap Investing with Paul Hill & Paul Scott

    2297: 2 P’s on a Pod: Small Cap Investing with Paul Hill & Paul Scott
    Jan 28 2026

    Watch on YouTube

    In this week’s upbeat smallcap show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 18 stock ideas.

    00:00 Life Science REIT
    03:30 Auction Technology Group
    08:40 Spire Healthcare
    13:10 CT Automotive
    16:45 Marston’s
    20:00 Mobico
    24:00 Cordel
    28:45 Proservice Building Services marketplace
    32:15 Use of Stop Losses
    37:00 Kooth
    41:45 EKF Diagnostics
    46:15 Paypoint
    49:40 Hargreaves Services
    53:25 Pebble Beach Systems
    57:20 Eagle Eye
    1:01:05 Lords Group Trading
    1:06:00 Craneware
    1:09:25 Eleco
    1:14:30 Venture Life

    #LABS #ATG #SPI #CTA #MARS #MCG #CRDL #PRO #KOO #EKF #PAY#HSP #PEB #EYE #LORD #CRW #ELCO #VLG
    Voir plus Voir moins
    1 h et 18 min
  • 2296: Q&A with Venture Life CFO Danny Wells

    2296: Q&A with Venture Life CFO Danny Wells
    Jan 27 2026

    Following yesterday’s positive and in line FY’25 trading update, CFO Danny Wells of Venture Life #VLG - a leading consumer healthcare products firm - kindly takes me through the:

    00:00 Key drivers underpinning the double digit top line growth
    05:10 Health & Her/Him brand07:15 Performance overseas & expansion into US
    11:10 outlook for (17 months ending) May’26 & utilisation of £34.3m cash mountain
    16:45 Closing remarks

    Disclosure: Venture Life is a Vox Markets client
    Voir plus Voir moins
    19 min